Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Braintree Laboratories, Inc. v. Breckenridge Pharmaceutical, Inc.
Case Number:
1:12-cv-06851
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 17, 2016
Braintree To Take Battle Over Laxative Patent To Fed. Circ.
Massachusetts-based pharmaceutical company Braintree told a New York federal court Thursday that it intends to appeal a judge's Tuesday order that a rival company does not infringe its patent that covers the laxative drug Suprep.
-
September 12, 2012
Braintree Takes Cypress To Court Over Generic Suprep
Braintree Laboratories Inc. hit Cypress Pharmaceutical Inc. with a patent suit Tuesday in New York federal court seeking to block Cypress from marketing a generic version of the laxative drug Suprep.